P-227 A phase II trial evaluating the Activity of caBozantinib in pre-treated pAtients with metastatic COlorectal cancer (mCRC): ABACO trial

Bibliographic Details
Title: P-227 A phase II trial evaluating the Activity of caBozantinib in pre-treated pAtients with metastatic COlorectal cancer (mCRC): ABACO trial
Authors: Martini, G., Troiani, T., Ciardiello, D., Napolitano, S., Famiglietti, V., Esposito, L., Arrichiello, G., De Falco, V., Cardone, C., Maiello, E., Latiano, T., Di Bisceglie, M., Varriale, E., Vitiello, P., Bardelli, A., Mariella, E., Avallone, A., Ciardiello, F., Martinelli, E.
Source: In Annals of Oncology June 2023 34 Supplement 1:S96-S96
Database: ScienceDirect
More Details
ISSN:09237534
DOI:10.1016/j.annonc.2023.04.283
Published in:Annals of Oncology
Language:English